Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Crisantaspase (Primary) ; Cytarabine; Fludarabine
- Indications Haematological malignancies
- Focus Therapeutic Use
- 19 Sep 2016 Planned primary completion date changed from 1 Jul 2019 to 1 Dec 2019.
- 19 Sep 2016 Planned initiation date changed from 1 Jul 2016 to 1 Dec 2016.
- 30 Mar 2016 New trial record